20721-17-9 Usage
Description
2-Hydroxy-5-methylpyrazine is a synthetic intermediate and a derivative of 2-Hydroxypyrazine (H952710). It is used in the synthesis of potential antioxidants and antibacterial agents as 2-substituted pyrazine derivatives.
Uses
Used in Pharmaceutical Industry:
2-Hydroxy-5-methylpyrazine is used as a synthetic intermediate for the development of potential antioxidants and antibacterial agents. Its unique chemical structure allows it to be incorporated into various pharmaceutical compounds, enhancing their efficacy and therapeutic properties.
Used in Antioxidant Applications:
As a derivative of 2-Hydroxypyrazine (H952710), 2-Hydroxy-5-methylpyrazine is used in the synthesis of antioxidants. These antioxidants can help protect cells from oxidative damage and reduce the risk of various diseases associated with oxidative stress.
Used in Antibacterial Applications:
2-Hydroxy-5-methylpyrazine is also used in the preparation of antibacterial agents as 2-substituted pyrazine derivatives. These agents can help combat bacterial infections and contribute to the development of new antimicrobial drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 20721-17-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,7,2 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 20721-17:
(7*2)+(6*0)+(5*7)+(4*2)+(3*1)+(2*1)+(1*7)=69
69 % 10 = 9
So 20721-17-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O/c1-4-2-7-5(8)3-6-4/h2-3H,1H3,(H,7,8)
20721-17-9Relevant articles and documents
Emimycin and its nucleoside derivatives: Synthesis and antiviral activity
Plebanek, Elzbieta,Lescrinier, Eveline,Andrei, Graciela,Snoeck, Robert,Herdewijn, Piet,De Jonghe, Steven
, p. 93 - 103 (2017/12/26)
The synthesis of emimycin, 5-substituted emimycin analogues and the corresponding ribo- and 2′-deoxyribonucleoside derivatives is described. Emimycin, its 5-substituted congeners and the ribonucleoside derivatives are completely devoid of antiviral activity against RNA viruses. In contrast, some of the 2′-deoxyribosyl emimycin derivatives are potent inhibitors of the replication of herpes simplex virus-1 and varicella-zoster virus, lacking cytotoxicity.
BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 57-58, (2010/02/07)
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.